BR9710453A - Inhibidor de produ-Æo de citocina composto de triazepina e intermedi rio para o mesmo - Google Patents

Inhibidor de produ-Æo de citocina composto de triazepina e intermedi rio para o mesmo

Info

Publication number
BR9710453A
BR9710453A BR9710453A BR9710453A BR9710453A BR 9710453 A BR9710453 A BR 9710453A BR 9710453 A BR9710453 A BR 9710453A BR 9710453 A BR9710453 A BR 9710453A BR 9710453 A BR9710453 A BR 9710453A
Authority
BR
Brazil
Prior art keywords
triazepine
same
cytokine production
production inhibitor
inhibitor composed
Prior art date
Application number
BR9710453A
Other languages
English (en)
Inventor
Yamamoto Yoshihisa
Msanori Shindo
Takeshi Nakamura
Original Assignee
Japan Tobacco Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Japan Tobacco Inc filed Critical Japan Tobacco Inc
Publication of BR9710453A publication Critical patent/BR9710453A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D255/00Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/04Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BR9710453A 1996-06-12 1997-06-11 Inhibidor de produ-Æo de citocina composto de triazepina e intermedi rio para o mesmo BR9710453A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP17426896 1996-06-12
JP9523797 1997-03-28
PCT/JP1997/002016 WO1997047622A1 (fr) 1996-06-12 1997-06-11 Inhibiteurs de production de cytokines, composes triazepine et intermediaires correspondants

Publications (1)

Publication Number Publication Date
BR9710453A true BR9710453A (pt) 1999-08-17

Family

ID=26436510

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9710453A BR9710453A (pt) 1996-06-12 1997-06-11 Inhibidor de produ-Æo de citocina composto de triazepina e intermedi rio para o mesmo

Country Status (9)

Country Link
EP (1) EP0934940A1 (pt)
CN (1) CN1227555A (pt)
AU (1) AU3106197A (pt)
BR (1) BR9710453A (pt)
CA (1) CA2258053A1 (pt)
IL (1) IL127516A0 (pt)
NO (1) NO985820L (pt)
PL (1) PL330635A1 (pt)
WO (1) WO1997047622A1 (pt)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1375465A4 (en) * 2001-04-03 2006-01-11 Eisai Co Ltd CYCLOOCTANON DERIVATIVE AND CYCLODECANON DERIVATIVE AND THEIR USE
WO2005089800A1 (ja) * 2004-03-17 2005-09-29 Locomogene, Inc. hsHRD3を含む医薬組成物
PT2722334E (pt) * 2009-11-05 2016-03-11 Glaxosmithkline Llc Inibidor do bromodomínio da benzodiazepina
GB0919426D0 (en) * 2009-11-05 2009-12-23 Glaxosmithkline Llc Novel compounds
DK2496582T3 (en) * 2009-11-05 2016-03-21 Glaxosmithkline Llc Benzodiazepine-BROMDOMAeNEINHIBITOR.
AU2015203454B2 (en) * 2009-11-05 2017-02-23 Glaxosmithkline Llc Benzodiazepine bromodomain inhibitor
ES2539964T3 (es) * 2009-11-05 2015-07-07 Glaxosmithkline Llc Procedimiento novedoso
EP2571503B1 (en) * 2010-05-14 2015-01-07 Dana-Farber Cancer Institute, Inc. Compositions and their use in treating neoplasia, inflammatory disease and other disorders
AU2015201727B2 (en) * 2010-05-14 2018-03-08 Dana-Farber Cancer Institute, Inc. Compositions and methods for treating neoplasia, inflammatory disease and other disorders
JP6022442B2 (ja) 2010-05-14 2016-11-09 ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド 男性用避妊組成物および使用方法
CA2799403C (en) 2010-05-14 2020-01-21 Dana-Farber Cancer Institute, Inc. Compositions and methods for treating leukemia
JP5715241B2 (ja) * 2010-05-14 2015-05-07 ダナ−ファーバー キャンサー インスティテュート, インコーポレイテッド 新生物、炎症性疾患、およびその他の障害を治療するための組成物および方法
ES2526671T3 (es) 2010-06-22 2015-01-14 Glaxosmithkline Llc Compuestos de benzotriazoldiazepina inhibidores de bromodominios
TWI549955B (zh) * 2010-08-04 2016-09-21 達納 法柏癌症學院有限公司 治療腫瘤形成、發炎疾病及其他病症之組成物及方法
AR084070A1 (es) 2010-12-02 2013-04-17 Constellation Pharmaceuticals Inc Inhibidores del bromodominio y usos de los mismos
WO2012075456A1 (en) 2010-12-02 2012-06-07 Constellation Pharmaceuticals Bromodomain inhibitors and uses thereof
EP2705039B1 (en) 2011-05-04 2017-07-26 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
WO2012174487A2 (en) 2011-06-17 2012-12-20 Constellation Pharmaceuticals, Inc. Bromodomain inhibitors and uses thereof
DE102011082013A1 (de) 2011-09-01 2013-03-07 Bayer Pharma AG 6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine
CN102603743B (zh) 2012-02-24 2014-05-28 南京天易生物科技有限公司 抗肿瘤的氮杂苯并[f]薁衍生物其制备方法及其用途
EP2864336B1 (en) 2012-06-06 2016-11-23 Constellation Pharmaceuticals, Inc. Benzo[b]isoxazoloazepine bromodomain inhibitors and uses thereof
TWI602820B (zh) 2012-06-06 2017-10-21 星宿藥物公司 溴域抑制劑及其用途
MX2015001880A (es) 2012-08-16 2015-05-11 Bayer Pharma AG 2,3-benzodiacepinas.
EP2900672B1 (de) 2012-09-28 2017-02-22 Bayer Pharma Aktiengesellschaft Bet-proteininhibitorische 5-aryl-triazolo-azepine
AU2014292888B2 (en) 2013-07-25 2018-03-22 Dana-Farber Cancer Institute, Inc. Inhibitors of transcription factors and uses thereof
CN105849110B (zh) 2013-11-08 2019-08-02 达纳-法伯癌症研究所有限公司 使用溴结构域和额外终端(bet)蛋白抑制剂的用于癌症的组合疗法
CA2936865A1 (en) 2014-01-31 2015-08-06 Dana-Farber Cancer Institute, Inc. Diaminopyrimidine benzenesulfone derivatives and uses thereof
EP3099693A4 (en) 2014-01-31 2017-08-16 Dana-Farber Cancer Institute, Inc. Uses of diazepane derivatives
SG11201607108XA (en) 2014-02-28 2016-09-29 Tensha Therapeutics Inc Treatment of conditions associated with hyperinsulinaemia
US9969747B2 (en) 2014-06-20 2018-05-15 Constellation Pharmaceuticals, Inc. Crystalline forms of 2-((4S)-6-(4-chlorophenyl)-1-methyl-4H-benzo[C]isoxazolo[4,5-e]azepin-4-yl)acetamide
CN106793775B (zh) 2014-08-08 2020-06-02 达纳-法伯癌症研究所股份有限公司 二氢碟啶酮衍生物及其用途
CA2955074A1 (en) 2014-08-08 2016-02-11 Dana-Farber Cancer Institute, Inc. Diazepane derivatives and uses thereof
US9975901B2 (en) * 2014-10-02 2018-05-22 Glaxosmithkline Intellectual Property (No. 2) Limited Crystalline solid state form of the benzene sulphonic acid salt of 2-[(4S)-6-(4-chlorophenyl)-1-methyl-8-(methyloxy)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamide
UA122130C2 (uk) 2014-10-27 2020-09-25 Тенша Терапеутікс, Інк. Інгібітори бромодомену
WO2016201370A1 (en) 2015-06-12 2016-12-15 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
CN108472299A (zh) 2015-09-11 2018-08-31 达纳-法伯癌症研究所股份有限公司 乙酰胺噻吩并***并二氮杂环庚三烯及其用途
KR20180049058A (ko) 2015-09-11 2018-05-10 다나-파버 캔서 인스티튜트 인크. 시아노 티에노트리아졸로디아제핀 및 그의 용도
SG11201803210YA (en) 2015-11-25 2018-05-30 Dana Farber Cancer Inst Inc Bivalent bromodomain inhibitors and uses thereof
EP3518898A4 (en) * 2016-10-03 2020-06-17 The Children's Medical Center Corporation PREVENTION AND TREATMENT OF DIABETIC NEPHROPATHY
EP3640253A4 (en) * 2017-05-31 2021-01-13 AYUMI Pharmaceutical Corporation 6H-THIEN [2,3-E] [1,2,4] TRIAZOLE [3,4-C] [1,2,4] TRIAZEPINE DERIVATIVE
BR112020025003A2 (pt) 2018-06-13 2021-03-23 Dybly Ag preparação de derivados de triazepina condensados e uso dos mesmos como inibidores de bet

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1489980A (en) * 1975-01-20 1977-10-26 Upjohn Co Reaction products of 3-amino-3,4-dihydro-4-hydroxy-4-phenylquinazolines
US4144233A (en) * 1977-02-16 1979-03-13 The Dow Chemical Company Method for preparing benzo-(1,3,4)-benzotriazepines
HUT77349A (hu) * 1994-11-18 1998-03-30 Japan Tobacco Inc. Eljárás csontritkulás kezelésére alkalmas kondenzált triazepinszármazékokat tartalmazó gyógyszerkészítmények előállítására, valamint új kondenzált triazepinszármazékok és intermedierjeik
JP2622673B2 (ja) * 1994-11-18 1997-06-18 日本たばこ産業株式会社 骨粗鬆症治療薬およびトリアゼピン化合物

Also Published As

Publication number Publication date
WO1997047622A1 (fr) 1997-12-18
IL127516A0 (en) 1999-10-28
AU3106197A (en) 1998-01-07
NO985820L (no) 1999-02-01
CN1227555A (zh) 1999-09-01
EP0934940A1 (en) 1999-08-11
PL330635A1 (en) 1999-05-24
NO985820D0 (no) 1998-12-11
CA2258053A1 (en) 1997-12-18

Similar Documents

Publication Publication Date Title
BR9710453A (pt) Inhibidor de produ-Æo de citocina composto de triazepina e intermedi rio para o mesmo
ID17427A (id) Popok sekali pakai
ID17346A (id) Popok sekali pakai
ID18096A (id) Popok sekali pakai
ID17545A (id) Popok sekali pakai
ID17591A (id) Popok sekali pakai
NO305833B1 (no) Naftylforbindelser, mellomprodukter og anvendelse av forbindelsene
ID18374A (id) Popok sekali pakai
DE69737330D1 (de) Supraleitendes keramisches laminiertes band
ID17571A (id) Popok sekali pakai
IS4898A (is) Sáraumbúðir
BR9709450A (pt) Inibidores de produção do s-cd23 e da secreção de tnt
ID18448A (id) Popok sekali pakai
ID16287A (id) Popok sekali pakai
DE69711223T2 (de) Verwendung von cordia dichotoma extrakten
ITBZ950045A0 (it) Gioiello e procedimento per la realizzazione dello stesso.
ID17419A (id) Komposisi dekafluoropentana
HRP970436B1 (en) Key intermediates in the manufacture of simvastatin
DE29606681U1 (de) Spielwürfel
FI963955A0 (fi) Markeringsboll och dess monteringsfoerfarande foer hoegspaenningsledningar
KR970000102A (ko) 피자호떡 및 그의 제조방법
ID16390A (id) Popok sekali pakai
KR960036082U (ko) 목걸이
ES1028230Y (es) Pieza para la construccion de barrotes de balcones y verjas.
DE29608779U1 (de) Zylinderspule

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENETA A 4A,5A,6A,7A E 8A ANUIDADES.